Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Jul 6, 2023
Date Accepted: Sep 21, 2023

The final, peer-reviewed published version of this preprint can be found here:

Telehealth Diabetes Prevention Program for Adults With Prediabetes in an Academic Medical Center Setting: Protocol for a Hybrid Type III Trial

Gamble A, Hughes AG, Guo Y, Vasaitis S, Bidwell JH, Christman BD, Khan T

Telehealth Diabetes Prevention Program for Adults With Prediabetes in an Academic Medical Center Setting: Protocol for a Hybrid Type III Trial

JMIR Res Protoc 2023;12:e50183

DOI: 10.2196/50183

PMID: 37955955

PMCID: 10682930

A Telehealth Diabetes Prevention Program for Adults with Prediabetes in an Academic Medical Center Setting: A Protocol for a Hybrid Type III Trial

  • Abigail Gamble; 
  • Alejandro G Hughes; 
  • Yan Guo; 
  • Siga Vasaitis; 
  • Josie H. Bidwell; 
  • Brian David Christman; 
  • Tamkeen Khan

ABSTRACT

Background:

Diabetes is a costly epidemic in the United States associated with both negative health and economic consequences. These consequences can be mitigated by participation in structured lifestyle change programs such as the National Diabetes Prevention Program (DPP) led by the Centers for Disease Control and Prevention. Mississippi consistently has among the highest rates of diabetes and prediabetes nationally. Implementing the National DPP through large healthcare systems can increase reach and accessibility for populations at the highest risk for diabetes. Translational research on the National DPP in Mississippi has not been studied.

Objective:

This study aims to evaluate the implementation and impact of the National DPP delivered using telehealth modalities at the University of Mississippi Medical Center in Jackson, Mississippi.

Methods:

An effectiveness-implementation hybrid type III research design is proposed. The study design is guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework and the Practical, Robust Implementation and Sustainability Model. Study participants include adult (≥18 years) patients eligible for the DPP with at least one encounter at one of three ambulatory clinic specialties (Lifestyle Medicine, Family Medicine, and Internal Medicine) between January 2019 and December 2023. National DPP eligibility criteria include a body mass index ≥25 and hemoglobin A1c between 5.7% and 6.4%.

Results:

The primary outcomes include patient referrals, participant enrollment, retention, and engagement, the incidence of diabetes, and healthcare resource utilization and costs. At baseline, 3,886 (14.9%) of 26,151 patients across three ambulatory clinic specialties had prediabetes. Of those patients with prediabetes, 1,025 (3.9%) were eligible for the National DPP. More than half (576, 56.2%) were aged 65 years or older, 79.8% (818) were Medicare beneficiaries, 65.7% (673) were females, and 70.7% (725) were obese.

Conclusions:

This is the first translational study of the National DPP in Mississippi. Findings will inform implementation strategies impacting the uptake and sustainability of the National DPP delivered in an academic medical setting using distance learning and telehealth modalities. Clinical Trial: ClinicalTrials.gov NCT04822480


 Citation

Please cite as:

Gamble A, Hughes AG, Guo Y, Vasaitis S, Bidwell JH, Christman BD, Khan T

Telehealth Diabetes Prevention Program for Adults With Prediabetes in an Academic Medical Center Setting: Protocol for a Hybrid Type III Trial

JMIR Res Protoc 2023;12:e50183

DOI: 10.2196/50183

PMID: 37955955

PMCID: 10682930

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.